Key result
The Empower Health chronic disease management model reduced systolic blood pressure by 9.4 mmHg and increased the proportion of patients with controlled pressure from 46% to 77% at 12 months (p<.001).
Why the study?
The Empower Health chronic disease management model was implemented to improve disease awareness, reduce disease burden, and improve the clinical effectiveness and efficiency of managing hypertension in Ghana and Kenya.
Does a novel chronic disease management model of care improve blood pressure control in patients in sub-Saharan Africa?
Cohort (n=1,266)
Yes
Does a novel chronic disease management model of care improve blood pressure control in patients in sub-Saharan Africa?
Mean Difference: -9.4
p-value: p=<.001
A novel chronic disease management model utilizing mobile technology and community partnerships significantly improved blood pressure control in a real-world sub-Saharan African cohort.
Supports community BP monitoring in sub-Saharan Africa; hypothesis-generating and requires RCTs before practice change.
A chronic disease management model of care (Empower Health) was launched in rural and urban areas of Ghana and Kenya in 2018. The goal was to improve disease awareness, reduce the burden of disease, and improve the clinical effectiveness and efficiency of managing hypertension. Leveraging the model, clinicians provide patients with tailored management plans. Patients accessed regular blood pressure checks at home, at the clinic, or at community-partner locations where they received real-time feedback. On the mobile application, clinicians viewed patient data, provided direct patient feedback, and wrote electronic prescriptions accessible through participating pharmacies. To date, 1266 patients had been enrolled in the "real-world" implementation cohort and followed for an average of 351 ± 133 days across 5 facilities. Average baseline systolic blood pressure (SBP) was 145 ± 21 mmHg in the overall cohort and 159 ± 16 mmHg in the subgroup with uncontrolled hypertension (n = 743) as defined by baseline SBP ≥ 140 mmHg. SBP decreased significantly through 12 months in both the overall cohort (-9.4 mmHg, p < .001) and in the uncontrolled subgroup (-17.6 mmHg, p < .001). The proportion patients with controlled pressure increased from 46% at baseline to 77% at 12 months (p < .001). In summary, a new chronic disease management model of care improved and sustained blood pressure control to 12 months, especially in those with elevated blood pressure at enrollment.
No takes yet. Share an insight, caveat, or question.
Otieno et al. (2021) conducted a cohort in Hypertension (n=1,266). Empower Health chronic disease management model vs. Baseline was evaluated on Change in systolic blood pressure at 12 months (MD -9.4 mmHg, p=<.001). The Empower Health chronic disease management model reduced systolic blood pressure by 9.4 mmHg and increased the proportion of patients with controlled pressure from 46% to 77% at 12 months (p<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: